Molina Healthcare Insider Dale B. Wolf Sells $330K of Stock
Dale B. Wolf sold 1,600 shares of Molina Healthcare, Inc. at $206.12 a share, worth $330K in total on Nov 13, 2026. Shares held after the trade: 14,337 (-10.0%).
Molina Healthcare Insider Richard M. Schapiro Sells $159K of Stock
Richard M. Schapiro sold 782 shares of Molina Healthcare, Inc. at $203.94 a share, worth $159K in total on Nov 10, 2026. Shares held after the trade: 11,833 (-6.2%).
Molina Healthcare CLO Jeff D. Barlow Sells $1.62M of Stock
Jeff D. Barlow, CLO, sold 8,000 shares of Molina Healthcare, Inc. at $203.07 a share, worth $1.62M in total on Nov 10, 2026. Shares held after the trade: 59,313 (-11.9%).
Molina Healthcare senior management will participate in the UBS Global Healthcare Conference on November 9, 2026. During the event, the company intends to reaffirm its full-year 2026 guidance, including GAAP diluted EPS of at least $2.38 and adjusted diluted EPS of at least $5.25.
For the quarter ended September 30, 2026, Molina Healthcare reported total revenue of $11.1 billion and net income of $38 million, a decrease from $79 million in the prior year period. The company faced a significant nine-month impairment charge of $93 million and saw a decrease in total membership to approximately 4.9 million members across 21 states.
Molina Healthcare reported third quarter 2026 financial results, including total revenue of $11.08 billion and GAAP diluted EPS of $0.73. The company reaffirmed its full-year 2026 guidance, expecting premium revenue of approximately $42 billion and adjusted earnings of at least $5.25 per diluted share.
Term
Q3 2026
“We are pleased with our third quarter results in this challenging environment and reaffirm our full year guidance. With the apparent plateauing of medical cost trend, which remains at elevated levels, and the strength of recent rate updates for 2027, we believe we are likely observing the beginning of the turn in Medicaid margins.”
Joseph Zubretsky, President and Chief Executive Officer